DCVC Bio, L.P. is a venture capital fund based in Palo Alto, California. According to its most recent Form D, filed May 14, 2019, it has sold $208,030,000 of interests to 41 investors since its first sale in Apr 2018. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include John Hamer; Zachary Bogue; Matthew Ocko.
- Total raised
- $208,030,000Cumulative sales reported on Form D
- Investors
- 41
- First sale
- Apr 20, 2018
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- John Hamer; Zachary Bogue; Matthew Ocko
- Latest Form D
- May 14, 2019
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about DCVC Bio, L.P.
What is the minimum investment for DCVC Bio, L.P.?
DCVC Bio, L.P.'s latest Form D, filed May 14, 2019, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in DCVC Bio, L.P.?
DCVC Bio, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has DCVC Bio, L.P. raised?
DCVC Bio, L.P. reports $208,030,000 sold from 41 investors on its Form D filed May 14, 2019. This is cumulative sales since the offering began, not current assets or performance.
Where is DCVC Bio, L.P. based?
DCVC Bio, L.P. is based in Palo Alto, California.
When did DCVC Bio, L.P. launch?
DCVC Bio, L.P. reports its first sale in Apr 2018.
Size compared with every venture capital fund
Raised more than 97% of the 2,216 venture capital funds based in California, and more than 99% of all 14,800 that report sales.